A Pharmacist’s View of Trulicity® (dulaglutide): A Once-Weekly Treatment Option for Long-term Care Residents With Type 2 Diabetes - PPN Episode 970

Share:

Listens: 0

SenioRX Radio

Business


Description: There are many challenges faced by residents, providers, and staff in LTC facilities, including the risk of hypoglycemia in residents with type 2 diabetes, the excessive reliance on sliding scale insulin, and comorbidities such as renal impairment. When managing LTC residents with type 2 diabetes, simplified treatment regimens with a low risk of hypoglycemia are preferred. Join us in this episode as Dr. Chad Worz and guest speakers Dr. Scott Drab and Dr. Naushira Pandya discuss how Trulicity, a GLP-1 RA, may be a suitable treatment option for adult LTC residents who need additional blood glucose control.